“The flat world will challenge cherished beliefs,” said Frank Douglas, Executive Director of the newly formed MIT Center for Biomedical Innovation. In this podcast, you’ll hear Douglas’ keynote speech on the challenges and opportunities for biopharmacology in a flat world at TiECON East in Boston. Until his recent retirement from industry, Dr. Douglas was Executive Vice President, Drug Innovation and Approval, and Chief Scientific Officer of Aventis SA, where he oversaw global pharmaceutical research, development and regulatory activities.
